Healthcare

Prescient Therapeutics’ PTX100 Phase 1b Basket Study Progressing Wel...

August 13, 2020 12:27 PM AEST | By Team Kalkine Media

Summary After demonstrating the safety at a dose of 1,000 mg/m2, Phase 1b study of PTX-100 will proceed to the increased dose of 2,000 mg/m2. Two...

Investors Smile with ASX-listed 1300 Smiles’ Stock Price Momentum

August 11, 2020 05:45 PM AEST | By Kunal Sawhney

The growing number of COVID-19 cases have led to several businesses going bankrupt with forced to ask their employees to work from home amid the pande...

Small Cap Healthcare Stock on A Tear as two leading candidates are t...

August 07, 2020 10:59 PM AEST | By Team Kalkine Media

A small cap healthcare company, whose stock has zoomed up 7x since the March lows, has embarked upon the race to undertake initial study of its drug c...

Prescient Therapeutics Onboards Internationally Renowned CAR-T Exper...

August 07, 2020 07:20 PM AEST | By Team Kalkine Media

Australia based clinical-stage oncology company Prescient Therapeutics Limited (ASX:PTX) appointed globally renowned cancer and Chimeric Antigen Recep...

Is Healthcare Rally Coming to an End? A needle on CSL, RMD, CUV

August 07, 2020 02:40 PM AEST | By Team Kalkine Media

COVID-19 pandemic has stress-tested the world, and so far, affected more than 18.61 million people including 702,642 reported deaths (as per WHO 3:17...

All you need to know about 4DMedical

August 04, 2020 08:02 PM AEST | By Team Kalkine Media

Summary The healthcare sector has been a bright spot in the otherwise dull IPO market in 2020 with seven IPOs already and more in the pipeline. 4D...

Prescient Therapeutics’ Progresses to Next Dose Level in PTX-200 AML...

August 03, 2020 06:20 PM AEST | By Team Kalkine Media

Summary Prescient Therapeutics’ Phase 1b trial with PTX-200 in AML progresses to the next dose level of 35 mg/m2 PTX-200. Phase 1b study of...

5 Pot Stocks and a Changed Perception: CAN, AC8, CGB, AGH, EOF

August 02, 2020 12:20 AM AEST | By Hina Chowdhary

While healthcare and biotech companies are fighting to find a cure for COVID-19 to put an end to the global misfortune caused by the novel coronavirus...

Can rising COVID-19 cases push these stocks further north? (RMD, FPH...

August 02, 2020 12:00 AM AEST | By Team Kalkine Media

Summary Australian Government’s response towards containing the Virus crisis was deemed successful worldwide.  Amid the pandemic, healt...

The emergence of Pro Medicus: How did the company grow sans external...

August 01, 2020 01:06 AM AEST | By Hina Chowdhary

Summary Pro Medicus stock has gained over 4,6000%, from once trading at 50 cents per share to ~$24 per share, at present. PME’s Radiology pl...

Are these Healthcare Stocks for Brave Investors: Osprey, Clinuvel, R...

July 31, 2020 10:59 PM AEST | By Kunal Sawhney

Summary GE Healthcare to exclusively distribute Osprey Medical Technology in Russia, Middle East, Central Asia, Europe, Africa, and Turkey. For th...

Aged Care and COVID Outbreaks: Estia Health

July 29, 2020 05:47 PM AEST | By Kunal Sawhney

Summary New cases in Victoria are rising, and signs of small outbreaks in NSW are also noticeable. The infection has also hit aged care facilities,...

Healthcare Space: Lens on ASX-listed Healius, Telix and Opthea

July 28, 2020 04:25 PM AEST | By Team Kalkine Media

With a world-class healthcare system in place and continuous efforts from the government and medical experts, Australia has managed to curb the spread...

Prescient Therapeutics to Raise A$6.5 million Via SPP to Advance Cli...

July 28, 2020 11:31 AM AEST | By Team Kalkine Media

Prescient Therapeutics (ASX:PTX), The ASX-listed biotechnology player developing targeted and personalised medicines for challenging cancers, announce...

Healthcare Corner: Lens on CSL and Opthea

July 26, 2020 12:20 AM AEST | By Kunal Sawhney

Summary University of Queensland’s COVID-19 vaccine candidate, for which biotech player CSL is providing technical assistance, began human tr...

Prescient Therapeutics’ Dazzling June Quarter Report, Achieved Signi...

July 23, 2020 11:43 AM AEST | By Team Kalkine Media

Summary In June 2020 quarter, Prescient added new assets in its belt with the most significant milestone of a next-generation immunotherapy platfor...

Remarkable! Assets of Prescient Selected for COVID-19 Antiviral Test...

July 22, 2020 12:49 PM AEST | By Team Kalkine Media

Clinical stage oncology company Prescient Therapeutics Limited (ASX:PTX) notified that two of its assets had been selected as Group 1 priority candida...

Did you miss the latest updates from small-cap healthcare players Re...

July 18, 2020 03:33 AM AEST | By Kunal Sawhney

The absence of a proven vaccine or treatment for COVID-19 has overshadowed the other challenges that we are currently facing relating the pandemic. Wi...

Imugene Receives Second Ethics Approval to Commence PD1-Vaxx Phase 1...

July 17, 2020 03:04 PM AEST | By Team Kalkine Media

Clinical stage immuno-oncology firm based in Australia, Imugene Limited (ASX:IMU) has received a second human research ethics approval from the Sydney...

Emerging Healthcare Space, a Treasure-trove with a Secured Future: L...

July 15, 2020 04:26 PM AEST | By Team Kalkine Media

Summary With growing cases of chronic ailments, increasing elderly population, and the rising demand for complex surgical procedures, the medical t...

5 ASX Companies Leveraging AI to Drive Growth in 2024

Markets